In Vivo Antibody Sampler Packs
In Vivo Antibody Sampler Packs
Curated panels of low-endotoxin, functional-grade in vivo antibodies for mouse immuno-oncology — each target paired with its matched isotype control, ready for checkpoint blockade, depletion and tumour-microenvironment studies.
Bundle & save 5% vs buying vials separatelyChoose your panel
Immune Checkpoint Blockade (ICB)
The three foundational checkpoint targets - PD-1, PD-L1 and CTLA-4 - each paired with its matched isotype control.
T-Cell Depletion
CD4, CD8alpha and CD3epsilon depletion antibodies with their matched isotype controls.
Immune Cell Depletion
A broad seven-antibody panel to deplete or modulate T cells, Tregs, NK cells, neutrophils and macrophages, with matched isotype controls.
LAG-3 Checkpoint Combination
LAG-3 combined with the core PD-1 / PD-L1 / CTLA-4 checkpoint axis, with matched isotype controls.
Tumour Microenvironment
PD-1, PD-L1 and CD8alpha antibodies for interrogating immune infiltration, with matched isotype controls.
Immuno-Oncology Discovery
A five-antibody discovery panel spanning the PD-1, PD-L1, CTLA-4 and LAG-3 checkpoints plus CD8alpha, with matched isotype controls.
Compare the packs
| Sampler Pack | Targets | Antibodies | Controls | Application focus |
|---|---|---|---|---|
| Immune Checkpoint Blockade (ICB) | PD-1, PD-L1, CTLA-4 | 3 | 3 | Checkpoint blockade, tumour immunology, combination immunotherapy, T-cell exhaustion studies. |
| T-Cell Depletion | CD4, CD8α, CD3ε | 3 | 2 | T-cell subset depletion, adoptive transfer, tumour immunology, autoimmunity and infection models. |
| Immune Cell Depletion | CD4, CD8α, NK1.1, CD25, Ly-6G, CD115, CD3ε | 7 | 5 | Lineage depletion, immune-cell contribution mapping, tumour microenvironment remodelling, mechanism-of-action studies. |
| LAG-3 Checkpoint Combination | LAG-3, PD-1, PD-L1, CTLA-4 | 4 | 4 | T-cell exhaustion, checkpoint blockade, tumour immunology, combination immunotherapy studies. |
| Tumour Microenvironment | PD-1, PD-L1, CD8α | 3 | 2 | Tumour microenvironment modulation, immune infiltration, checkpoint combination studies. |
| Immuno-Oncology Discovery | PD-1, PD-L1, CTLA-4, LAG-3, CD8α | 5 | 4 | Immuno-oncology discovery, multi-checkpoint blockade, T-cell exhaustion, combination immunotherapy. |
Not sure which panel fits your study?
Our team can help you match a sampler pack to your model, or build a custom panel.
Talk to our team